By 
Add-on acquisitions are common across private equity. What’s uncommon is doing 10 or more of them per platform company, then producing average revenue growth above 400%. That’s the track record Reeve Waud has built at Waud Capital Partners across its healthcare portfolio, and the approach tells you something about how the firm thinks about scaling.
WCP doesn’t acquire a healthcare company and hope the market does the rest. Each platform investment comes with a thesis about which sub-sector is fragmented, which geographic or service gaps exist, and which add-on targets would fill them. The firm’s internal database of 2.2 million companies supports that thesis by mapping the competitive field before a deal closes.
Step One: Pick the Niche
Waud Capital Partners has concentrated its healthcare investing in sectors where dozens or hundreds of small operators serve a common patient base without coordinating with one another. Behavioral health fit that profile in the mid-2000s, with scattered clinics and small hospital groups and no national network. Gastroenterology looked similar a few years later, with thousands of independent physician practices operating across the country.
Reeve Waud told Buyouts magazine in 2018 that WCP was also looking at niche areas like veterinary care, home health, and specialty pharmacy, all sectors defined by the same pattern of fragmentation Reeve Waud.
Step Two: Install an Operator, Then Acquire
Once WCP identifies a niche and acquires a platform company, its in-house talent team recruits or installs an experienced CEO. The executive’s job isn’t to sit in the chair and manage. It’s to lead an acquisition campaign. Bolt-on deals follow quickly, sometimes overlapping. WCP’s five-person human capital team supports this process from sourcing through integration.
Acadia Healthcare ran this pattern from 2005 to 2011, acquiring behavioral health facilities across multiple states before going public Acadia Healthcare. GI Alliance followed a similar track, consolidating gastroenterology practices until a 2022 recapitalization valued the company at approximately $2.2 billion.
Step Three: Revenue Growth as the Exit Thesis
WCP doesn’t rely on financial engineering to produce returns. The firm’s exit depends on demonstrable revenue and earnings growth, the kind that comes from adding locations, patients, and service lines through acquisition. Average portfolio revenue growth above 400% is the headline number, and it explains why buyers like Apollo Global Management Reeve Waud and Thoma Bravo have been on the other side of WCP’s exits.
Reeve Waud has managed this process across more than 450 acquisitions. WCP now oversees $4.6 billion in assets, with roughly 70 professionals executing the same playbook the firm has refined for three decades.
Comments